#
Mometasone Inhalation, oral/nebulization
  • Treatments
  • Asthma
  • Maintenance
  • Mometasone

Mometasone

Medically reviewed by Drugs.com. Last updated on Apr 5, 2022.

Commonly used brand name(s)

In the U.S.

  • Asmanex HFA
  • Asmanex Twist

In Canada

  • Asmanex Twisthaler
  • Azmax Twisthaler

Available Dosage Forms:

  • Powder
  • Aerosol Powder

Therapeutic Class: Anti-Inflammatory

Pharmacologic Class: Mometasone

Uses for mometasone

Mometasone is used to help prevent the symptoms of asthma and improve breathing. When used regularly every day, inhaled mometasone decreases the number and severity of asthma attacks. However, it will not relieve an asthma attack that has already started.

Mometasone HFA is used as a maintenance treatment for the prevention and control of asthma symptoms in patients 5 years of age and older.

Inhaled mometasone belongs to the family of medicines known as corticosteroids (cortisone-like medicines). It works by preventing certain cells in the lungs and breathing passages from releasing substances that cause asthma symptoms.

Mometasone is available only with your doctor's prescription.

Before using mometasone

In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For mometasone, the following should be considered:

Allergies

Tell your doctor if you have ever had any unusual or allergic reaction to mometasone or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.

Pediatric

Appropriate studies performed to date have not demonstrated pediatric-specific problems that would limit the usefulness of inhaled mometasone to prevent asthma in children 4 years of age and older. However, safety and efficacy have not been established in children younger than 4 years of age.

Appropriate studies performed to date have not demonstrated pediatric-specific problems that would limit the usefulness of inhaled mometasone HFA to prevent asthma in children 5 years of age and older. However, safety and efficacy have...